| 29 | 1/1 | 返回列表 |
| 查看: 1233 | 回復(fù): 28 | |||
| 【有獎(jiǎng)交流】積極回復(fù)本帖子,參與交流,就有機(jī)會(huì)分得作者 我是學(xué)術(shù)女 的 75 個(gè)金幣 ,回帖就立即獲得 1 個(gè)金幣,每人有 1 次機(jī)會(huì) | |||
[交流]
荷蘭格羅寧根大學(xué)藥物遞送方向招CSC博士生
|
|||
|
研究方向:抗腫瘤藥物納米遞送系統(tǒng)聯(lián)合腫瘤免疫治療、新型藥物遞送系統(tǒng)、腦靶向藥物遞送系統(tǒng) 1. 導(dǎo)師簡介: Flávia Sousa, Tenure-Track Assistant Professor。Sousa 教授以第一作者或通訊作者身份在 Nature Reviews Materials、Advanced Drug Delivery Reviews、Journal of Controlled Release 等國際頂級期刊發(fā)表與腫瘤治療相關(guān)的藥物遞送研究論文40余篇,累計(jì)總被引超過2500次,H因子達(dá)31。她在基于腫瘤治療的納米藥物遞送系統(tǒng)研究領(lǐng)域處于世界領(lǐng)先水平。被評為麻省理工科技創(chuàng)新35歲以下杰出青年,同時(shí)也是國際控釋學(xué)會(huì)(Controlled Release Society)杰出青年科學(xué)家。她主持多項(xiàng)國家級及歐盟科研項(xiàng)目,包括瑞士國家科學(xué)基金會(huì)(SNSF)資助的 NCCR Bio-Inspired Materials 項(xiàng)目、Falling Walls 基金會(huì)女性科學(xué)家計(jì)劃等,累計(jì)科研經(jīng)費(fèi)超過100萬歐元。她曾獲得包括瑪麗·居里獎(jiǎng)學(xué)金(Marie Skłodowska-Curie Fellowship)、國際控釋學(xué)會(huì)杰出青年科學(xué)家獎(jiǎng)在內(nèi)的多項(xiàng)國際獎(jiǎng)項(xiàng)。 此外Sousa 教授還被邀請參加TED演講,分享她對推動(dòng)社會(huì)平等且健康的科學(xué)文化的看法,視頻鏈接為:https://www.youtube.com/watch?v=KkjQeSsb8_U 更多關(guān)于Flávia Sousa教授的信息,可查看她的主頁介紹:https://research.rug.nl/en/persons/fl%C3%A1via-moreira-de-sousa,或者 https://www.flaviasousasci.com/ Flávia Sousa教授的郵箱為:flavia.sousa@rug.nl 感興趣的同學(xué)可以和她聯(lián)系。 2. 研究經(jīng)歷: 2024年7月 – 至今,Tenure-Track Assistant Professor,荷蘭格羅寧根大學(xué) 2024年1月 – 2024年6月,訪問高級研究員,瑞士日內(nèi)瓦大學(xué) / AGORA癌癥研究中心 2022年7月 – 2024年6月,高級研究員 3. 代表性成果: 1. F. Haamedat, B. Mendes, J. Conniot, L. D. Di Filippo, M. Chorilli, A. Schroeder, J. Conde, F. Sousa*, Engineered nanomaterials for glioblastoma nanovaccination, Nat Rev Mat, 9, 628–642 (2024) (Featured on September COVER) 2. F. Sousa, Emerging cytokine delivery with nanomedicine for brain cancer treatment, Expert Opinion on Drug Delivery, 21 (4), 513-516 (2024) 3. F. Sousa*, H. Lee, M. Almeida, A. Bazzoni, B. B. Rother-Rutishauser, A. Petri-Fink, Immunostimulatory nanoparticles delivering cytokines as a novel cancer nanoadjuvant to empower glioblastoma immunotherapy, Drug Deliv Transl Res, 14 (10), 2655-2667, (2023) 4. F. Sousa, Brain-Targeted Drug Delivery, Pharmaceutics, 14(9), 1835, (2022) 5. F. Diniz, M. Azevedo, F. Sousa, H. Osório, D. Campos, P. Sampaio, J. Gomes, B. Sarmento, C. Reis, Polymeric nanoparticles targeting Sialyl-Tn in gastric cancer: A live tracking under flow conditions, Materials Today Bio,16, 100417, (2022) 6. F. Sousa, A.I. Costa-Pereira, A. Cruz, F.J. Ferreira, M. Gouveira, J. Bessa, B. Sarrmento, R.D.M. Travasso, I.M. Pinto, Intratumoral VEGF nanotrapper reduces glioblastoma vascularization and tumor cell mass, J Control Release, 339, 381-390, (2021) 7. J.M.W.D. Neto, J.C. Silva, F. Sousa, O.S.L. Gonçalves, M.C. A. Wanderley, B. Sarmento, C.A. Lima, M.T. Neves-Petersen, A. L. F. Porto, Structural and functional analysis of broad pH and thermal stable protease from Penicilium aurantiogriseum URM 4622, Preparative Biochem & Biotech, (2021) 8. B. Sánchez-Dengra, I. González-Álvarez, F. Sousa, M. Bermejo, M. González-Álvarez, B. Sarmento, In vitro model for predictiong the access and distribution of drugs in the brain using hCMEC/D3 cells, Eur. J. Pharm. Biopharm, 163: 120-126, (2021) 9. J. Finbloom, F. Sousa, M. M. Stevens, T.A. Desai, Engineering the Drug Carrier Biointerface to Overcome Biological Barriers to Drug Delivery, Adv. Drug Deliv. Rev.,167: 89-108, (2020) 10. A. Jaradat, M.H. Macedo, F. Sousa, K. Arkill, C. Alexander, J. Aylott, B. Sarmento, Prediction of the enhanced absorption of insulin across triple co-cultured model using mucus penetrating PLGA NPs, Inter. J. Pharm., 585:119516, (2020) 11. A. Baião, F. Sousa, A. Oliveira, C. Oliveira, B. Sarmento, Effective intracelular delivery of bevacizumab via PEGylated polymeric nanoparticles targeting CD44v6 receptor in colon cancer cells, Biomaterials Science, 8:3720-3729, (2020) 12. J.P. Martins, J. das Neves, M. de la Fuente, C. Celia, H. Florindo, N. Günday-Türeli, A. Popat, J. L. Santos, F. Sousa, R. Schmid, J. Wolfram, B. Sarmento, H. Santos, The solid progress of nanomedicine, Drug Deliv. and Transl. Res., 10(3): 726-729, (2020) 13. M. Qin, J. Jin, Q. Saiding, Y. Xiang, Y. Wang, F. Sousa, B. Sarmento, W. cui, X. Chen, In situ inflammatory-regulated drug-loaded hydrogels for promoting pelvic flood repair, J. Controlled Release, 322, 375-389, (2020) 14. C. Pacheco, F. Sousa, B.Sarmento, Chitosan-based Nanomedicine for Brain Delivery: Where Are We Heading?, Reactive and Functional Polymers, Reactive and Functional Polymers, 146:104430, (2020) 15. J. Yang, F. Wang, Y. Lu, J. Qi, L. Deng, F. Sousa, B. Sarmento, Xiangyang Xua, Wenguo Cui, Recent advance of erythrocyte-mimicking nanovehicles: from bench to bedside, J. Control Release, 20; 314:81-91, (2019) 16. F. Sousa, H.K. Dhaliwal, F. Gattacceca, B. Sarmento, M. Amiji, Enhanced Anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles, J. Control Release, 22;309:37-47, (2019) 17. R.P. Moura, C. Martins, F. Sousa, S. Pinto, B. Sarmento, Blood-Brain Barrier receptors and transporters: An insight on their function and how to exploit them though nanotechnology, Expert Opinion on Drug Delivery, 16(3):271-285, (2019) 18. N.N. Ferreira, B.L. Caetano, F.I. Boni, F. Sousa, M. Magnani, B. Sarmento, B.S.F. Cury, M.P.D. Gremião, Alginate-Based Delivery Systems for Bevacizumab Local Therapy: In vitro structural features and release properties, J. Pharm. Sciences, 108(4):1559-1658, (2019) 19. P. J. Kennedy, F. Sousa, D. Ferreira, C. Pereira, M. Nestor, C. Oliveira, P. L. Granja, B. Sarmento, Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6, Acta Biomater., 81:208-218, (2018) 4. 重要獎(jiǎng)項(xiàng): 2023年 麻省理工科技評論評選“歐洲35歲以下創(chuàng)新者” 2023年 荷蘭特溫特大學(xué) TEDx 演講者 2023年 入選Falling Walls基金會(huì)“女性科學(xué)人才”項(xiàng)目 2022年 《Pharmaceutics》期刊差旅獎(jiǎng) 2021年 瑪麗·居里COFUND資助 2019年 COST行動(dòng)計(jì)劃CA15216差旅獎(jiǎng) 2019年 葡美基金會(huì)(FLAD)資助獎(jiǎng) 2019年 控釋學(xué)會(huì)(Controlled Release Society)杰出青年科學(xué)家獎(jiǎng) 2019年 SPLC-CRS會(huì)議最佳口頭報(bào)告獎(jiǎng) 2018年 COST行動(dòng)計(jì)劃CA17140納米醫(yī)學(xué)資助 2018年 控釋學(xué)會(huì)杰出青年科學(xué)家獎(jiǎng) 2017年 富布賴特獎(jiǎng)學(xué)金獲得者 5. 科研項(xiàng)目 2024年 格羅寧根大學(xué)科研啟動(dòng)基金 – 650,000 歐元 2023年 NCCR仿生材料獨(dú)立資助項(xiàng)目 – 4,000 瑞士法郎 2022年 NCCR仿生材料與瑞士國家科學(xué)基金會(huì)(SNSF)資助的女性科學(xué)家獨(dú)立研究獎(jiǎng)學(xué)金 – 245,000 瑞士法郎 2021年 瑪麗·居里博士后COFUND獎(jiǎng)學(xué)金 – 100,000 歐元 2019年 FLAD(葡美基金會(huì))資助 – 800 歐元 2018年 富布賴特研究資助 – 15,000 歐元 |
» 搶金幣啦!回帖就可以得到:
+2/248
+1/84
+1/83
+1/36
+1/30
+1/27
+1/20
+1/14
+2/11
+1/11
+1/10
+1/9
+1/8
+1/7
+3/6
+1/5
+1/4
+1/4
+1/4
+1/1







| 29 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 歡迎采礦、地質(zhì)、巖土、計(jì)算機(jī)、人工智能等專業(yè)的同學(xué)報(bào)考 +8 | pin8023 2026-02-28 | 11/550 |
|
|---|---|---|---|---|
|
[考研] 304分材料專碩求調(diào)劑 +3 | qiuzhigril 2026-03-03 | 5/250 |
|
|
[考研] 復(fù)試調(diào)劑 +4 | 杰尼龜aaa 2026-03-03 | 4/200 |
|
|
[考研] 306求調(diào)劑 +7 | 張張張張oo 2026-03-03 | 7/350 |
|
|
[考研] 266材料化工求調(diào)劑 +3 | 哇塞王帥 2026-03-03 | 3/150 |
|
|
[考研] 085600材料與化工 298 調(diào)劑 +3 | 小西笑嘻嘻 2026-03-03 | 3/150 |
|
|
[考研] 江蘇省農(nóng)科院招調(diào)劑1名 +5 | Qwertyuop 2026-03-01 | 5/250 |
|
|
[碩博家園] 2025屆雙非化工碩士畢業(yè),申博 +4 | 更多的是 2026-02-27 | 5/250 |
|
|
[考研] 環(huán)境調(diào)劑 +5 | 柒槿levana 2026-03-01 | 5/250 |
|
|
[考研] 材料學(xué)碩318求調(diào)劑 +15 | February_Feb 2026-03-01 | 17/850 |
|
|
[考研] 材料類考研調(diào)劑 +6 | gemmgemm 2026-03-01 | 7/350 |
|
|
[考研] 0857調(diào)劑 +6 | 一ll半 2026-02-28 | 8/400 |
|
|
[考研] 考研復(fù)試調(diào)劑,過國家線的同學(xué)都可報(bào)名 +7 | 黑!在干嘛 2026-02-28 | 8/400 |
|
|
[考研]
|
好好好1233 2026-02-28 | 16/800 |
|
|
[考研] 11408,學(xué)碩276求調(diào)劑 +3 | 崔wj 2026-03-02 | 5/250 |
|
|
[考研] 0856材料與化工,270求調(diào)劑 +11 | YXCT 2026-03-01 | 13/650 |
|
|
[考研] 一志愿鄭大材料學(xué)碩298分,求調(diào)劑 +6 | wsl111 2026-03-01 | 6/300 |
|
|
[論文投稿]
Optics letters投稿被拒求助
30+3
|
luckyry 2026-02-26 | 4/200 |
|
|
[考研] 304求調(diào)劑 +3 | 52hz~~ 2026-02-28 | 5/250 |
|
|
[高分子] 求環(huán)氧樹脂研發(fā)1名 +3 | 孫xc 2026-02-25 | 11/550 |
|